Anavex Strengthens Board of Directors

Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL - News) announces the appointment of Dr. Cameron Durrant to its Board of Directors. - January 16, 2008 - Anavex Life Sciences Corp.

Anavex 7-1037 Demonstrates Chemotherapeutic Potential Without Toxic Side Effects for the Treatment of Colorectal Cancer, Other Types of Solid Tumors

ANAVEX 7-1037 has been shown to kill human HCT116 colon cancer cells in advanced pre-clinical studies. - January 16, 2008 - Anavex Life Sciences Corp.

Trevigen Launches Cultrex BME PathClear

Trevigen announces the immediate availability of PathClear" Basement Membrane Extract in the Cultrex® product line. - January 11, 2008 - Trevigen, Inc.

AnaSpec Introduces Ten New Catalog Peptides

This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced ten (10) new catalog peptides and one new unusual amino acid. MSL8; [Met256]-OVA (257-264)- Cat# 62573-5 Sequence: MSIINFEKL MSL8; [Met256]-OVA (257-264)- Cat# 62573-1 Sequence: MSIINFEKL OVA... - January 04, 2008 - AnaSpec, EGT Group

Avoiding Steroids and Their Side Effects Should be Component in New Year’s Resolution of Athletes, Law Enforcement and Paramilitary

Avoiding Steroids and Their Side Effects Should be Component in New Year’s Resolution of Athletes, Law Enforcement and Paramilitary

Unparalleled drug-free gains in strength, stamina and mental performance attainable through natural energetic alternative to steroids and banned performance enhancing drugs providing powerful ergogenic effects rivaling steroids, blood doping and other dangerous performance enhancement techniques while enhancing deep delta sleep, cardiovascular efficiency, cellular repair and mental acuity. - January 01, 2008 - EarthPulse Tech, LLC

"Clinical and Economical Considerations for Iv Push Drug Delivery" by Industry Expert Richard Rosenfeld is Now Accessible on Expert411.com for Media and Professional Use

The “Clinical and Economical Considerations For IV Push Drug Delivery” technical paper – authored by Industry Expert Richard Rosenfeld, RPh, MBA, for Baxa Corporation – is now accessible at Expert411.com for media and professional reference. The paper is an overview of the historical background for IV push and a model for implementation of a successful program. - December 27, 2007 - Baxa Corporation

AnaSpec Introduces Sixteen New Catalog Peptides

This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced sixteen (16) new catalog peptides. [Cys17]-beta-Amyloid (1-17)- Cat# 62473 This peptide amino acids 1 to 17 is a modified fragment of the b-amyloid peptide; with cysteine substituted for valine... - December 20, 2007 - AnaSpec, EGT Group

AnaSpec Introduces First Colorimetric SensoLyte™ MMP Assay Kit

AnaSpec has introduced its first quantitative and homogeneous colorimetric MMP assay kit. - December 19, 2007 - AnaSpec, EGT Group

AnaSpec Introduces New Selection of Dye-Labeled Beta-Amyloid Peptides

AnaSpec introduces a new line of labeled amyloid peptides. - December 16, 2007 - AnaSpec, EGT Group

AnaSpec Introduces 10 New Catalog Antibodies

Continuing to rapidly expand its antibody offerings, AnaSpec added ten (10) new catalog antibodies to its growing collection. Anti-ATF2 (pT69/71) - Cat# 54323, 50 µg/250 µl Host: rabbit polyclonal; Species Reactivity: Human; Mouse; Rat; Zebrafish; Bovine; Applications: WB Anti-ATF2... - December 15, 2007 - AnaSpec, EGT Group

The Holiday Gift for the Pet Who Has Everything

The Holiday Gift for the Pet Who Has Everything

Pulsed magnetic fields provide strong anti-aging effects while enhancing physical performance in older pets where trauma, arthritis or age related joint deformity has resulted in chronic pain, loss of mobility and subsequent changes in behavior. - December 14, 2007 - EarthPulse Tech, LLC

AnaSpec Releases New Antibodies Brochure

With a collection that has been rapidly expanded in the last few years, AnaSpec has organized its growing selection of antibodies into its newest antibodies brochure. The brochure showcases: • Primary antibodies • HRP, AP and biotin conjugated secondary antibodies • Patented... - December 14, 2007 - AnaSpec, EGT Group

ValveXchange Wins The Third Annual Faegre & Benson Venture Showcase Award, Presented At BioWest 2007

ValveXchange has won the third annual Faegre & Benson Venture Showcase Award at the BioWest 2007 conference in Denver. The announcement is made by Chris Shapard, Deputy Director of the Colorado BioScience Association (CBSA), who says the $10,000 Venture Showcase Award was again provided by the Faegre & Benson law firm and announced at the Colorado Bioscience Association (CBSA) Awards luncheon at the Grand Hyatt Friday. - December 09, 2007 - Colorado BioScience Association

Gamma Medica-Ideas Announces the Sale of a Fully Digital Multi-Modality Pre-Clinical Imaging System to Louisiana State University Health Sciences Center

Gamma Medica-Ideas Inc. (GM-I), the world leader in developing and delivering digital medical imaging devices for the pre-clinical and clinical markets, has announced the sale of a fully digital multi-modality molecular imaging system for installation at Louisiana State University Health Sciences... - December 07, 2007 - Gamma Medica-Ideas

AnaSpec Introduces Eight New Catalog Peptides and One Unusual Amino Acid

This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced eight (8) new catalog peptides and one new unusual amino acid. - December 07, 2007 - AnaSpec, EGT Group

AnaSpec Introduces New Collection of Bcl Peptides

AnaSpec introduced a collection of peptides related to the family of proteins called Bcl-2 (B-cell lymphoma 2) for use in cancer research or cell cycle research. - December 06, 2007 - AnaSpec, EGT Group

AnaSpec Introduces 17 New Anti-Tau Antibodies

Continuing to rapidly expand its antibody offerings, AnaSpec added seventeen (17) new anti-Tau antibodies to its growing collection. Anti-Tau (paired181) - Cat# 54961, 50 µg Host: rabbit polyclonal; Species Reactivity: Human; Mouse; Rat; Applications: WB Anti-Tau (paired198;199;202;205) -... - December 06, 2007 - AnaSpec, EGT Group

Baxa Corporation Launches MedBoard™ Medication Tracking System

Baxa announces the introduction of MedBoard, the first wireless medication tracking system. MedBoard is featured at the Baxa booth (no. 2106) at the annual American Society of Health-System Pharmacists Midyear Clinical Meeting in Las Vegas, December 3 – 5, 2007. With its dynamic order monitoring, MedBoard reduces waste by identifying time-sensitive orders and ensuring on-time delivery. - December 03, 2007 - Baxa Corporation

Baxa Corporation Launches Repeater™ Pump II with P2™ Technology

Baxa announces the introduction of its next-generation Repeater Pump, the first no-calibration pharmacy pump, featuring unique P2 technology. The Repeater Pump II is featured at the Baxa booth (no. 2106) at the annual American Society of Health-System Pharmacists Midyear Clinical Meeting in Las Vegas, December 3 – 5, 2007. - December 03, 2007 - Baxa Corporation

Colorado BioScience Association Announces Winners of Its 2007 Awards Program, Honoring the Best of Colorado's Bioscience Industry

The Colorado BioScience Association (CBSA) has released winners of its 2007 Awards Program. Official presentation of the awards occurs Friday, December 7, 11:45 a.m. to 1:15 p.m., at the CBSA’s annual awards luncheon. Held in conjunction with the 2007 BioWest Conference at the Grand Hyatt Denver, registration information is available at the BioWest Conference website. - November 29, 2007 - Colorado BioScience Association

AnaSpec Celebrates the Holidays with Its Customers

AnaSpec will be adding a one pound box of See’s Candy into every order placed from now through the end of the year. - November 29, 2007 - AnaSpec, EGT Group

AnaSpec Introduces AnaTagTM Protein Labeling Kits with HiLytePlusTM

AnaSpec introduced a new series of AnaTagTM Labeling Kits now available with the revolutionary new HiLytePlus™ series of long-wavelength dyes. - November 29, 2007 - AnaSpec, EGT Group

Baxa to Sponsor Exhibitor’s Theatre: How to Get Your Administration to Buy What You Need: Building a Solid Business Plan 101 at ASHP

Colorado-based pharmacy products manufacturer, Baxa Corporation, is sponsoring a program at the annual American Society of Health-System Pharmacists’ Midyear Clinical Meeting in Las Vegas, December 3rd. The speaker will discuss key financial analyses and metrics and how to use them to build a compelling business plan. - November 27, 2007 - Baxa Corporation

Baxa to Sponsor Exhibitor’s Theatre: The Pros and Cons of Standardized Parenteral Nutrition at ASHP Midyear Clinical Meeting in Las Vegas

Colorado-based pharmacy products manufacturer, Baxa Corporation, is sponsoring a program at the annual American Society of Health-System Pharmacists’ Midyear Clinical Meeting in Las Vegas, December 3rd. The speaker will discuss parenteral nutrition safety issues and the differences between standardized formulations and a standardized process. - November 26, 2007 - Baxa Corporation

Gamma Medica-Ideas and Mayo Clinic Collaborate on New Breast Cancer Research Project

Gamma Medica-Ideas Inc. (GM-I), the world leader in developing and delivering digital medical imaging devices for the pre-clinical and clinical markets, has announced its collaboration with Mayo Clinic in an important, new breast cancer research project. The main goal of the project, funded by a... - November 23, 2007 - Gamma Medica-Ideas

NovaBay Pharmaceuticals Featured in November/December Issue of PharmaVOICE

Company Executives Offer “Crystal Ball” Predictions. VP of Research Discusses Need for New Approaches in Anti-Infectives. - November 22, 2007 - NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Retains The Investor Relations Group of New York

IRG to Communicate the Company’s Clinical Development Programs - November 21, 2007 - NovaBay Pharmaceuticals, Inc.

Baxa Corporation Signs Strategic Reseller Agreement with MedKeeper for Web-Based Productivity Tool

Baxa Corporation announces its agreement with MedKeeper to market and sell a Web-based program that tracks pharmacy doses from order entry to delivery. Under the agreement, Baxa Corporation has exclusive sales and distribution rights for all worldwide healthcare markets for the MedKeeper software. - November 21, 2007 - Baxa Corporation

BioCentury Editor Dr. Karen Bernstein Added to the Roster of National Speakers for The BioWest 2007 Conference and Expo

Karen Bernstein, Ph.D., Co-Founder, Chairman & Editor-in-Chief of the BioCentury family of publications, including the well-read “The Bernstein Report on Biobusiness” has been added to the roster of national speakers for BioWest 2007 on Thursday, December 6 (12:15 – 1 p.m.) at the Grand Hyatt Denver. Dr. Bernstein replaces Colorado Governor Bill Ritter for the Thursday luncheon address. The Governor's commitments required his speech be rescheduled to the 2:30 – 3 p.m. time slot the same day. - November 19, 2007 - Colorado BioScience Association

AnaSpec Introduces HiLytePlus™ Labeled Secondary Antibodies & Streptavidin

AnaSpec introduces a new collection of secondary antibodies and streptavidin labeled with the new HiLytePlus™ series of fluorescent dyes. - November 17, 2007 - AnaSpec, EGT Group

Glycosan BioSystems Announces the Release of Extracel Sponge-96

Glycosan BioSystems launched its new product for cell-based assays Extracel Sponge-96. - November 15, 2007 - Glycosan BioSystems, Inc.

Baxa Corporation to Bring USP, ASHE and CAHED Together for a Joint Forum on USP 797 Compliance at the STAR Center

Baxa Corporation announces plans to launch new course offering with an industry forum on USP 797 compliance and facility design. The forum, held in the STAR (Skills Training, Academics and Resources) Center, will bring together industry leaders to better understand the requirements of USP 797 and their practical application for facility design and environmental control. - November 14, 2007 - Baxa Corporation

Clinical Trials in Russia, 3rd Quarter 2007

According to SynRG Orange Paper, in the 3rd Quarter 2007, the overall volume of the clinical trials in Russia and its basic parameters are generally the same as in the corresponding quarter of the last year. In the 3rd Quarter 2007 RosZdravNadzor (RZN) has issued 141 approvals for conducting new clinical trials, which is 2% more than in Q3 2006. - November 14, 2007 - Synergy Research Group

Five Top Colorado Bioscience Company CEOs Present at This Year’s BioWest Mature Company Forum

CEOs from five of Colorado’s top bioscience companies will present at the BioWest 2007 Mature Company Forum on December 6th – registration is still open for the two-day BioWest event, which is the Rocky Mountain Region’s premier bioscience conference and expo. CEOs featured in the Mature Company Forum include Bob Conway, Array Biopharma; Greg Baldwin, Baxa Corporation; Jeff Probst, Blue Sun Biodiesel; Chris Smith, Cochlear Americas; and Bob Grieve, Heska Corporation. - November 12, 2007 - Colorado BioScience Association

AnaSpec Introduces Thirteen New Catalog Peptides

Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced thirteen (13) new catalog peptides. Bak BH3 (71-89)- Cat# 62261 This peptide is amino acids 71 to 89 fragment of the Bak BH3 domain .The BH3 domain plays a critical role in mediating the cell death... - November 11, 2007 - AnaSpec, EGT Group

AnaSpec Introduces HiLytePlus™ – AnaSpec’s Highest Performance Fluorescent Dyes

This week AnaSpec announced the release of the HiLytePlus™ series of fluorescent dyes. Demonstrating even greater brightness than AnaSpec’s HiLyte Fluor™ line, this series represents the next generation in AnaSpec’s line of high performance fluorescent dyes. With excitation... - November 09, 2007 - AnaSpec, EGT Group

Six Finalists Selected for the BioWest 2007 Venture Showcase Competition, Presenting World-Changing Technologies

Novel diagnostics focusing on the management of therapeutics, innovative nanoscale drug and vaccine delivery technology, pioneering use of small molecule therapeutic products for treating multiple diseases of the brain, cutting edge technology for the production of algae-based biofuels, new... - November 02, 2007 - Colorado BioScience Association

Xcelience’s Scientific Director Selected to Lead Key Sessions on Upcoming Conferences

Dr. Steve Bannister’s expertise requested for several speaking engagements over the next year - October 31, 2007 - Xcelience, LLC

AnaSpec Introduces Anti-Keratin-18 & 19 Antibodies

AnaSpec has introduced two new catalog antibodies: Anti-Keratin-18 and Anti-Keratin-19. Intermediate filaments (IFs), together with actin microfilaments and tubulin microtubules, comprise the three major cytoskeletal networks that are found in most eukaryotic cells.1 Keratins, which are the... - October 24, 2007 - AnaSpec, EGT Group

Glycosan BioSystems, Inc. to Attend AACR Molecular Targets and Cancer Therapeutics

Glycosan BioSystems, Inc. a manufacturer of innovative products for three-dimensional cell culture, will be attending the American Association for Cancer Research's Molecular Targets and Cancer Therapeutics conference to be held in San Francisco on October 22-26, 2007. - October 19, 2007 - Glycosan BioSystems, Inc.

AnaSpec Introduces Labeled RGD Peptide for In Vivo Imaging

Leveraging its dual expertise in peptides and detection reagents, AnaSpec has released c[RGDyK(HiLyte FluorTM 750)], a labeled RGD peptide that has produced significant imaging results in a recent in vivo research study. Extracellular matrix proteins containing the Arg-Gly-Asp (RGD) motif, and... - October 18, 2007 - AnaSpec, EGT Group

AnaSpec Introduces One New Amino Acid and Two New Catalog Peptides

Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced one new unusual amino acid and two new catalog peptides. HRP Prorenin; Decoy Handle Region Peptide- Cat# 62118 Sequence: RILLKKMPSV Fmoc-HomoArg(Pbf)-OH- Cat# 60004-1/ 60004-5 TP508;... - October 17, 2007 - AnaSpec, EGT Group

Nanion's Technology Nominated for Presidential Innovation Award

Nanion's Planar Patch Clamp Technology has been nominated for the German Future Award 2007 - October 13, 2007 - Nanion Technologies GmbH

Dr. William Heyward on the Forefront of the Fight Against the World's Deadliest Communicable Diseases

For nearly three decades, William Heyward has been on the forefront in the fight against some of the world's deadliest communicable diseases. HIV/AIDS, Ebola, haemophilius influenzae, hepatitis B, and hepatic cancer are among the many illnesses he has focused his attention on in places as far-flung as Zaire, Alaska, South America and Thailand. Dr. Heyward has lived on the leading edge of research on the causes, effects and prevention of devastating diseases among some of the world's poorest area - October 12, 2007 - William Heyward

AnaSpec Launches New SensoLyteTM Caspase-8 Assay Kit

AnaSpec introduces its newest offering – the SensoLyte™ Homogeneous AFC Caspase-8 Assay Kit - October 11, 2007 - AnaSpec, EGT Group

Baxa Corporation Launches PadLock™ Set Saver for IV Safety

Baxa Corporation’s New PadLock Set Saver locks in IV safety through its unique design. PadLock is the first and only aseptic IV administration set storage solution that can be swabbed and re-used. Effective for multiple uses, the Set Saver attaches to an IV administration set and replaces the need for sterile, single-use caps. - October 10, 2007 - Baxa Corporation

Better Stem Cell Culture

Extracel-HP makes stem cell culture more realistic - October 07, 2007 - Glycosan BioSystems, Inc.

AnaSpec Introduces Improved Website Search Tool

AnaSpec has introduced Smart Search, an optimized site search engine for locating items in AnaSpec’s expansive collection of products. - October 07, 2007 - AnaSpec, EGT Group

AnaSpec Introduces Anti-Keratin-18 & 19 Antibodies

AnaSpec has introduced two new catalog antibodies: Anti-Keratin-18 and Anti-Keratin-19. Intermediate filaments (IFs), together with actin microfilaments and tubulin microtubules, comprise the three major cytoskeletal networks that are found in most eukaryotic cells.1 Keratins, which are the... - October 06, 2007 - AnaSpec, EGT Group

Baxa Corporation Recognized with Art Directors Club of Denver Merit Award

A Baxa Corporation Internet microsite, designed to promote the Rapid-Fill Automated Syringe Filler, wins merit award from Art Directors Club of Denver. The Art Directors Club of Denver Annual Show features the best examples of marketing communications from across the Front Range. Nationally recognized judges from Seattle, Minneapolis, Birmingham and Kansas City participated in awarding more than 100 entries in this year’s program. - October 04, 2007 - Baxa Corporation

Press Releases 2,901 - 2,950 of 3,227